Pharmacotherapy for Liver Cirrhosis and Its Complications / edited by Xingshun Qi, Yongping Yang
Contributor(s): Qi, Xingshun, editor literario | Yang, Yongping, editor literario
Material type:
E-bookPublisher: Singapore : Springer International Publishing, 2022Edition: 1st edition 2022.Description: 1 recurso en línea (XII, 240 páginas) : 20 ilustraciones, 16 ilustraciones a color.ISBN: 9789811926150.Subject: Cirrosis hepática -- Tratamiento
| FarmacoterapiaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC848 .C5 2022 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.25123078 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC848 .C5 2020 EB The Critically Ill Cirrhotic Patient : Evaluation and Management | RC848 .C5 2020 EB Frailty and Sarcopenia in Cirrhosis : The Basics, the Challenges, and the Future | RC848 .C5 2021 EB Variceal Bleeding in Liver Cirrhosis | RC848 .C5 2022 EB Pharmacotherapy for Liver Cirrhosis and Its Complications | RC848.C5 C667 2015 EB Complications of Cirrhosis : Evaluation and Management | RC848.F27 2020 EB Liver Failure : Acute and Acute on Chronic | RC848.F29 2021 EB Fasciolosis : Causes, Challenges and Controls |
Anti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.
This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
There are no comments on this title.